Patent details

Basic Information

Publication number:

EP2205318

PCT Application Number:

PCT/EP/2008/008919

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP088417241

PCT Publication Number:

WO/2009/053038

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

COMBINATION THERAPY OF A TYPE II ANTI-CD20 ANTIBODY WITH A PROTEASOME INHIBITOR

French Title of Invention:

THÉRAPIE COMBINÉE D'UN ANTICORPS ANTI-CD20 DE TYPE II AVEC UN INHIBITEUR DU PROTÉASOME

German Title of Invention:

KOMBINATIONSTHERAPIE MIT EINEM TYP-II-CD20-ANTIKÖRPER MIT EINEM PROTEASOMHEMMER

SPC Number:

Dates

Filing date:

22/10/2008

Grant date:

19/11/2014

EP Publication Date:

19/11/2014

PCT Publication Date:

30/04/2009

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

14/07/2010

EP B1 Publication Date:

19/11/2014

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

22/10/2015

Expiration date:

22/10/2028

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

22/10/2008

 

 

Name:

Roche Glycart AG

Address:

Wagistrasse 18, 8952 Schlieren-Zuerich, Switzerland (CH)

Inventor

1

Name:

FERTIG Georg

Address:

Germany (DE)

2

Name:

FRIESS Thomas

Address:

Germany (DE)

3

Name:

KLEIN Christian

Address:

Switzerland (CH)

4

Name:

UMANA Pablo

Address:

Switzerland (CH)

Priority

Priority Number:

07020820

Priority Date:

24/10/2007

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07K 16/28;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages